ArticleThe Journal of veterinary medical science2022

Sorafenib inhibits tumor cell growth and angiogenesis in canine transitional cell carcinoma.

Shohei Yokota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.